View of Evaluation of the Collateral Activity of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer

Return to Article Details Evaluation of the Collateral Activity of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer Download Download PDF